RA Capital Management’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $190M | Hold |
10,860,977
| – | – | 3.19% | 8 |
|
|
2025
Q1 | $137M | Hold |
10,860,977
| – | – | 2.28% | 11 |
|
|
2024
Q4 | $115M | Hold |
10,860,977
| – | – | 1.52% | 17 |
|
|
2024
Q3 | $157M | Hold |
10,860,977
| – | – | 1.82% | 15 |
|
|
2024
Q2 | $92.4M | Hold |
10,860,977
| – | – | 1.22% | 22 |
|
|
2024
Q1 | $111M | Buy |
10,860,977
+1,401,299
| +15% | +$14.3M | 1.41% | 22 |
|
|
2023
Q4 | $51.8M | Hold |
9,459,678
| – | – | 0.81% | 30 |
|
|
2023
Q3 | $35.8M | Buy |
9,459,678
+6,450,000
| +214% | +$24.4M | 0.7% | 39 |
|
|
2023
Q2 | $20.2M | Hold |
3,009,678
| – | – | 0.38% | 43 |
|
|
2023
Q1 | $19.6M | Hold |
3,009,678
| – | – | 0.44% | 45 |
|
|
2022
Q4 | $25.7M | Buy |
+3,009,678
| New | +$25.7M | 0.52% | 44 |
|
|
2022
Q1 | – | Sell |
-1,742,186
| Closed | -$11.6M | – | 104 |
|
|
2021
Q4 | $11.6M | Hold |
1,742,186
| – | – | 0.2% | 78 |
|
|
2021
Q3 | $17.4M | Hold |
1,742,186
| – | – | 0.24% | 66 |
|
|
2021
Q2 | $53.8M | Hold |
1,742,186
| – | – | 0.86% | 37 |
|
|
2021
Q1 | $76M | Hold |
1,742,186
| – | – | 1.15% | 27 |
|
|
2020
Q4 | $80.7M | Buy |
+1,742,186
| New | +$80.7M | 1.13% | 27 |
|